126 related articles for article (PubMed ID: 37321014)
1. Cerebrospinal fluid soluble CD27 is associated with CD8
El Mahdaoui S; Husted SR; Hansen MB; Cobanovic S; Mahler MR; Buhelt S; von Essen MR; Sellebjerg F; Romme Christensen J
J Neuroimmunol; 2023 Aug; 381():578128. PubMed ID: 37321014
[TBL] [Abstract][Full Text] [Related]
2. Multiplex assessment of cerebrospinal fluid biomarkers in multiple sclerosis.
Mahler MR; Søndergaard HB; Buhelt S; von Essen MR; Romme Christensen J; Enevold C; Sellebjerg F
Mult Scler Relat Disord; 2020 Oct; 45():102391. PubMed ID: 32679525
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Level of Soluble CD27 Is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder.
Liu B; Zhong X; Lu Z; Qiu W; Hu X; Wang H
Neuroimmunomodulation; 2018; 25(4):185-192. PubMed ID: 30423585
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
Komori M; Blake A; Greenwood M; Lin YC; Kosa P; Ghazali D; Winokur P; Natrajan M; Wuest SC; Romm E; Panackal AA; Williamson PR; Wu T; Bielekova B
Ann Neurol; 2015 Jul; 78(1):3-20. PubMed ID: 25808056
[TBL] [Abstract][Full Text] [Related]
5. T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes.
Wong YYM; van der Vuurst de Vries RM; van Pelt ED; Ketelslegers IA; Melief MJ; Wierenga AF; Catsman-Berrevoets CE; Neuteboom RF; Hintzen RQ
Mult Scler; 2018 Nov; 24(13):1715-1724. PubMed ID: 30019626
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosis.
Cencioni MT; Magliozzi R; Palmisano I; Suwan K; Mensi A; Fuentes-Font L; Villar LM; Fernández-Velasco JI; Migallón NV; Costa-Frossard L; Monreal E; Ali R; Romozzi M; Mazarakis N; Reynolds R; Nicholas R; Muraro PA
J Neuroinflammation; 2024 Apr; 21(1):91. PubMed ID: 38609999
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis.
Hintzen RQ; Paty D; Oger J
J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):791-3. PubMed ID: 10329758
[TBL] [Abstract][Full Text] [Related]
8. Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.
Talbot J; Højsgaard Chow H; Mahler M; Buhelt S; Holm Hansen R; Lundell H; Vinther-Jensen T; Hellem MNN; Nielsen JE; Siebner HR; von Essen MR; Sellebjerg F
Mult Scler Relat Disord; 2022 Dec; 68():104209. PubMed ID: 36257152
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
[TBL] [Abstract][Full Text] [Related]
10. CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Lundblad K; Zjukovskaja C; Larsson A; Cherif H; Kultima K; Burman J
Neurol Neuroimmunol Neuroinflamm; 2023 Sep; 10(5):. PubMed ID: 37311645
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
Ahlbrecht J; Martino F; Pul R; Skripuletz T; Sühs KW; Schauerte C; Yildiz Ö; Trebst C; Tasto L; Thum S; Pfanne A; Roesler R; Lauda F; Hecker M; Zettl UK; Tumani H; Thum T; Stangel M
Mult Scler; 2016 Aug; 22(9):1202-14. PubMed ID: 26493127
[TBL] [Abstract][Full Text] [Related]
12. Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MS.
Novakova L; Singh AK; Axelsson M; Ståhlman M; Adiels M; Malmeström C; Zetterberg H; Borén J; Lycke J; Cardell SL; Blomqvist M
J Neurochem; 2018 Aug; 146(3):322-332. PubMed ID: 29676479
[TBL] [Abstract][Full Text] [Related]
13. Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers.
Mohammadinasr M; Montazersaheb S; Molavi O; Kahroba H; Talebi M; Ayromlou H; Hejazi MS
Neuromolecular Med; 2023 Sep; 25(3):402-414. PubMed ID: 37020076
[TBL] [Abstract][Full Text] [Related]
14. The alterations of cerebrospinal fluid TNF-alpha and TGF-beta2 levels in early relapsing-remitting multiple sclerosis.
Grzegorski T; Iwanowski P; Kozubski W; Losy J
Immunol Res; 2022 Oct; 70(5):708-713. PubMed ID: 35729473
[TBL] [Abstract][Full Text] [Related]
15. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis.
Novakova L; Axelsson M; Khademi M; Zetterberg H; Blennow K; Malmeström C; Piehl F; Olsson T; Lycke J
J Neurochem; 2017 Apr; 141(2):296-304. PubMed ID: 27787906
[TBL] [Abstract][Full Text] [Related]
17. Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis.
Holm Hansen R; Talbot J; Højsgaard Chow H; Bredahl Hansen M; Buhelt S; Herich S; Schwab N; Hellem MNN; Nielsen JE; Sellebjerg F; von Essen MR
Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35835563
[TBL] [Abstract][Full Text] [Related]
18. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients.
Hintzen RQ; van Lier RA; Kuijpers KC; Baars PA; Schaasberg W; Lucas CJ; Polman CH
J Neuroimmunol; 1991 Dec; 35(1-3):211-7. PubMed ID: 1659587
[TBL] [Abstract][Full Text] [Related]
20. Effects of anti-CD20 therapy on circulating and intrathecal follicular helper T cell subsets in multiple sclerosis.
El Mahdaoui S; Hansen MM; Hansen MB; Hvalkof VH; Søndergaard HB; Mahler MR; Romme Christensen J; Sellebjerg F; von Essen MR
Clin Immunol; 2024 Jul; 264():110262. PubMed ID: 38788886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
